Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yasunobu Miyake, Kenichi Asano, Hitomi Kaise, Miho Uemura, Manabu Nakayama, Masato Tanaka
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2268–2278 doi:10.1172/JCI31990
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 7
DCs were not affected by DT treatment in CD169-DTR mice.

Wild-type (+/+) or CD169-DTR (+/CD169DTR) mice were injected with (+DT) or without (–DT) 10 μg/kg of DT. Spleens were obtained 4 days after DT treatment. (A) Cryosections of the spleen were stained with CD11c (DCs) and B220 (B cells). Original magnification, ×200. (B) Single-cell suspensions of splenocytes were stained with CD11c alone (total DCs) or in combination with CD8α (lymphoid DCs) or CD11b (myeloid DCs) and analyzed by flow cytometry.